Related Experiment Videos
[Interferon as a bronchospastic factor in patients with bronchial asthma]
M Krasnowska1, J Małolepszy, E Liebhart
1Katedry i Kliniki Chorób Wewnetrznych i Alergologii AM we Wrocławiu.
Pneumonologia I Alergologia Polska
|January 1, 1992
Summary
Inhaled interferon alpha (Hu IFN-alpha) can trigger bronchospasm in individuals with asthma. This study found that inhaling Hu IFN-alpha significantly reduced lung function (FEV1) in asthmatic patients.
Area of Science:
- Immunology
- Pulmonology
- Respiratory Medicine
Context:
- Asthma is a chronic respiratory condition characterized by airway inflammation and hyperresponsiveness.
- Interferons are cytokines with antiviral and immunomodulatory properties.
- The effects of inhaled interferons on airway function in asthmatics are not well understood.
Purpose:
- To investigate the effects of inhaled human interferon alpha (Hu IFN-alpha) on lung function in asthmatic patients during a symptom-free period.
Summary:
- Twenty-three asthmatic subjects inhaled aerosolized Hu IFN-alpha at doses of 4000 and 8000 units.
- Inhalation of Hu IFN-alpha resulted in a significant decline in forced expiratory volume in 1 second (FEV1).
- Average FEV1 decline was 9.9% after the first dose and 6.6% after the second dose.
Impact:
- Inhaled Hu IFN-alpha can induce bronchospastic reactions in asthmatic individuals.
- These findings suggest a potential risk associated with the use of inhaled interferons in asthma management.
- Further research is warranted to explore the mechanisms and clinical implications of this observation.